Lucira Health ROCE 2024

Lucira Health Aktienanalyse

What does Lucira Health do?

Lucira Health is an American company specializing in the development and manufacturing of diagnostic devices and kits. It was founded in 2013 and is headquartered in Emeryville, California. The company was founded by Dr. Erik Engelson and Dr. Jessie Zhou, both of whom have experience in developing molecular diagnostic tests. Lucira Health initially provided research and development services for other companies before deciding to develop its own products. In 2018, the company won first place in the XPRIZE Rapid-Response COVID-19 competition and received a $5 million award for the development of a rapid COVID-19 test. Lucira Health's business model focuses on the development and manufacturing of diagnostic devices and kits. The company works closely with other organizations to develop faster, more effective, and cost-efficient tests. It also utilizes partnerships and licensing agreements to market its devices and tests. Lucira Health has two main divisions: molecular diagnostics and point-of-care diagnostics. In molecular diagnostics, the company offers a range of tests specifically designed for molecular diagnostics, including tests for diagnosing infectious diseases such as COVID-19, influenza, and hepatitis B and C. In point-of-care diagnostics, Lucira Health specializes in the development of point-of-care diagnostic devices that are designed to deliver fast and accurate test results within minutes. The company has developed the first FDA-approved COVID-19 test kit that can be used at home. The test kit provides results within 30 minutes and requires only a nasal swab. In addition to its diagnostic products, the company has also developed a platform that allows users to submit and track their test results online. In conclusion, Lucira Health is a company focused on the development of diagnostic devices and kits. With its emphasis on molecular and point-of-care diagnostics, the company has developed a range of tests that can be used to diagnose infectious diseases. With its history of collaboration with other organizations and the $5 million award from the XPRIZE Rapid-Response COVID-19 competition, Lucira Health is expected to continue developing innovative products that contribute to the improvement of public health. Lucira Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Lucira Health's Return on Capital Employed (ROCE)

Lucira Health's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Lucira Health's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Lucira Health's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Lucira Health’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Lucira Health stock

What is the ROCE (Return on Capital Employed) of Lucira Health this year?

The ROCE of Lucira Health is -0.3 undefined this year.

How has the ROCE (Return on Capital Employed) of Lucira Health developed compared to the previous year?

The ROCE of Lucira Health has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Lucira Health?

A high Return on Capital Employed (ROCE) indicates that Lucira Health has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Lucira Health?

A low ROCE (Return on Capital Employed) can indicate that Lucira Health has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Lucira Health impact the company?

An increase in the ROCE of Lucira Health can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Lucira Health affect the company?

A decrease in ROCE of Lucira Health can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Lucira Health?

Some factors that can affect Lucira Health's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Lucira Health so important for investors?

The ROCE of Lucira Health is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Lucira Health take to improve the ROCE?

To improve the ROCE, Lucira Health can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Lucira Health pay?

Over the past 12 months, Lucira Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lucira Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Lucira Health?

The current dividend yield of Lucira Health is .

When does Lucira Health pay dividends?

Lucira Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lucira Health?

Lucira Health paid dividends every year for the past 0 years.

What is the dividend of Lucira Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lucira Health located?

Lucira Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lucira Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lucira Health from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Lucira Health pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Lucira Health in the year 2023?

In the year 2023, Lucira Health distributed 0 USD as dividends.

In which currency does Lucira Health pay out the dividend?

The dividends of Lucira Health are distributed in USD.